Pink004的个人主页 - 老虎社区

Pink004

Pink004

暂无个人介绍

IP属地：未知

166关注

4粉丝

0主题

0勋章

2021-05-31

Omg

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克贸易暂停继续凌晨 03:28 不可用原因</blockquote>

2021-05-25

Yes

抱歉，原内容已删除

2021-06-15

Agreed 👍

抱歉，原内容已删除

2021-06-10

Haiz

抱歉，原内容已删除

2021-05-19

Wow

JD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将公布第一季度收益：前景如何？</blockquote>

2021-07-06

No

抱歉，原内容已删除

2021-06-13

Good

抱歉，原内容已删除

2021-06-02

Good

抱歉，原内容已删除

2021-07-16

Good

抱歉，原内容已删除

2021-07-08

👍

U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3577341055310022","uuid":"3577341055310022","gmtCreate":1614421827085,"gmtModify":1621389672847,"name":"Pink004","pinyin":"pink004","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":166,"tweetSize":30,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.42%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":808626694,"gmtCreate":1627575067718,"gmtModify":1631884986818,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/808626694","repostId":"1165345369","repostType":4,"isVote":1,"tweetType":1,"viewCount":3451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170737981,"gmtCreate":1626450507243,"gmtModify":1631884986830,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170737981","repostId":"1179740731","repostType":4,"isVote":1,"tweetType":1,"viewCount":2740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":144576348,"gmtCreate":1626308171784,"gmtModify":1631884986841,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/144576348","repostId":"1158174802","repostType":4,"repost":{"id":"1158174802","kind":"news","pubTimestamp":1626307894,"share":"https://www.laohunote.com/m/news/1158174802?lang=zh_CN&edition=full","pubTime":"2021-07-15 08:11","market":"us","language":"en","title":"Here's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158174802","media":"Motley Fool","summary":"Shareholders could be in store for even more gains.Shares of $Apple$ climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure amon","content":"<p>  Shareholders could be in store for even more gains.  <img src=\"https://static.tigerbbs.com/1ccdffb5c79b7b06da6ba63aa32eabb0\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote>股东可能会获得更多收益。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> Shares of&nbsp;<b><a href=\"https://laohu8.com/S/AAPL\">Apple</a></b>&nbsp;climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.</p><p><blockquote>股份<b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>在分析师发表乐观评论和有关 iPhone 生产率大幅上升的报道后，周三攀升至历史新高。截至下午2点美国东部时间，该股价格上涨超过2%，这使得苹果的市值达到了惊人的2.5万亿美元。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Thetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.</p><p><blockquote>据彭博社报道，这家科技巨头正努力今年生产多达 9000 万部最新 iPhone。据报道，苹果正准备将出货量比 2020 年提高 20%。</blockquote></p><p> Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.</p><p><blockquote>苹果预计将于9月份推出最新一代iPhone。升级的处理器、显示屏和摄像头都将有助于增加该设备在消费者中的吸引力。</blockquote></p><p> Meanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.</p><p><blockquote>与此同时，分析师 Samik Chatterjee 周三将苹果列入摩根大通的“关注名单”。查特吉预计，受 iPhone 和 Mac 销量增长的推动，苹果股价将达到 175 美元。如果他是正确的，股东可以从该股目前接近 149 美元的价格中获得约 17% 的收益。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Apple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.</p><p><blockquote>苹果正处于5G推动的iPhone超级周期之中。第五代无线技术有望为用户提供极快的下载速度，并实现一系列先进技术。</blockquote></p><p> Surging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.</p><p><blockquote>iPhone 销量的飙升也推动了对苹果稳步扩展的一系列服务的需求。这些高利润率收入流反过来又有助于推动公司惊人的盈利增长。<a href=\"https://laohu8.com/S/ISBC\">投资者</a>——对未来更大利润的前景感到兴奋——周三将这家科技巨头的股价推高至历史新高。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Apple Stock Jumped to a New All-Time High Wednesday<blockquote>这就是苹果股价周三跃升至历史新高的原因</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-07-15 08:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  Shareholders could be in store for even more gains.  <img src=\"https://static.tigerbbs.com/1ccdffb5c79b7b06da6ba63aa32eabb0\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote>股东可能会获得更多收益。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么事</b></blockquote></p><p> Shares of&nbsp;<b><a href=\"https://laohu8.com/S/AAPL\">Apple</a></b>&nbsp;climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.</p><p><blockquote>股份<b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>在分析师发表乐观评论和有关 iPhone 生产率大幅上升的报道后，周三攀升至历史新高。截至下午2点美国东部时间，该股价格上涨超过2%，这使得苹果的市值达到了惊人的2.5万亿美元。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Thetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.</p><p><blockquote>据彭博社报道，这家科技巨头正努力今年生产多达 9000 万部最新 iPhone。据报道，苹果正准备将出货量比 2020 年提高 20%。</blockquote></p><p> Apple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.</p><p><blockquote>苹果预计将于9月份推出最新一代iPhone。升级的处理器、显示屏和摄像头都将有助于增加该设备在消费者中的吸引力。</blockquote></p><p> Meanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.</p><p><blockquote>与此同时，分析师 Samik Chatterjee 周三将苹果列入摩根大通的“关注名单”。查特吉预计，受 iPhone 和 Mac 销量增长的推动，苹果股价将达到 175 美元。如果他是正确的，股东可以从该股目前接近 149 美元的价格中获得约 17% 的收益。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Apple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.</p><p><blockquote>苹果正处于5G推动的iPhone超级周期之中。第五代无线技术有望为用户提供极快的下载速度，并实现一系列先进技术。</blockquote></p><p> Surging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.</p><p><blockquote>iPhone 销量的飙升也推动了对苹果稳步扩展的一系列服务的需求。这些高利润率收入流反过来又有助于推动公司惊人的盈利增长。<a href=\"https://laohu8.com/S/ISBC\">投资者</a>——对未来更大利润的前景感到兴奋——周三将这家科技巨头的股价推高至历史新高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/07/14/heres-why-apple-stock-jumped-to-a-new-all-time-hig/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","03086":"华夏纳指","AAPL":"苹果","NGD":"New Gold"},"source_url":"https://www.fool.com/investing/2021/07/14/heres-why-apple-stock-jumped-to-a-new-all-time-hig/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158174802","content_text":"Shareholders could be in store for even more gains.\n\n\nWhat happened\nShares of Apple climbed to a record high on Wednesday, following bullish analyst commentary and reports of substantially higher iPhone production rates. As of 2 p.m. EDT, the stock's price was up more than 2%, which placed Apple's market capitalization at a staggering $2.5 trillion.\nSo what\nThetechtitan is striving to manufacture as many as 90 million of its newest iPhones this year, according to Bloomberg. Apple is reportedly preparing to boost shipments by 20% compared to 2020's levels.\nApple is expected to debut its latest-generation iPhones in September. Upgraded processors, displays, and cameras should all help to add to the device's allure among consumers.\nMeanwhile, analyst Samik Chatterjee added Apple to J.P. Morgan's \"focus list\" on Wednesday. Chatterjee sees Apple's shares reaching $175, fueled by higher iPhone and Mac sales. If he's correct, shareholders could enjoy gains of roughly 17% from the stock's current price near $149.\nNow what\nApple is in the midst of a 5G-fueled iPhone supercycle. The fifth-generation wireless technology promises to provide users with blazingly fast download speeds and enable a host of advanced technologies.\nSurging iPhone sales are also boosting demand for Apple's steadily expanding array of services. These high-margin revenue streams, in turn, are helping to fuel the company's stunning earnings growth. Investors -- excited about the prospect of even greater profits ahead -- are bidding up the tech giant's shares to new all-time highs Wednesday.","news_type":1,"symbols_score_info":{"03086":0.9,"09086":0.9,"AAPL":0.9,"NGD":0.9}},"isVote":1,"tweetType":1,"viewCount":4109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145913981,"gmtCreate":1626185818443,"gmtModify":1631884986852,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>:這篇文章不錯，轉發給大家看看","listText":"good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>:這篇文章不錯，轉發給大家看看","text":"good//@螞蟻東尼:這篇文章不錯，轉發給大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/145913981","repostId":"155626240","repostType":1,"repost":{"id":155626240,"gmtCreate":1625414672374,"gmtModify":1625585035721,"author":{"id":"3468322318173915","authorId":"3468322318173915","name":"阳光财经","avatar":"https://static.tigerbbs.com/ae4ab676f150a8d357cb5f3e4956d1a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3468322318173915","idStr":"3468322318173915"},"themes":[],"title":"","htmlText":"\n \n \n  美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。\n \n","listText":"美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。","text":"美股分析：重大节日，纳指奔向16000点。 重大节日再次创出历史新高，只要拿稳前5大科技股，就没有不赚钱的。 今天的视频我们会分析，为什么纳指有希望奔向16000点，然后PK一下$苹果(AAPL)$ 和$微软(MSFT)$ ，两大股王，谁更值得买入。我已经买了其中一只，现在觉得稳稳的。","images":[{"img":"https://static.tigerbbs.com/ba1369048ae43f622980bb91c23c7c43","width":"0","height":"0"}],"top":1,"highlighted":2,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155626240","isVote":1,"tweetType":2,"object":{"id":"db32d9da23344a86826b18e89f2adb7a","tweetId":"155626240","title":"美股分析：重大节日，纳指奔向16000点。","videoUrl":"http://v.tigerbbs.com/16254146691280ea7d902da8ded6f3ddaa98f7f579134.mp4","poster":"https://static.tigerbbs.com/ba1369048ae43f622980bb91c23c7c43","shareLink":"http://v.tigerbbs.com/16254146691280ea7d902da8ded6f3ddaa98f7f579134.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143092981,"gmtCreate":1625751825943,"gmtModify":1631884986868,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/143092981","repostId":"1184325113","repostType":4,"repost":{"id":"1184325113","kind":"news","pubTimestamp":1625750497,"share":"https://www.laohunote.com/m/news/1184325113?lang=zh_CN&edition=full","pubTime":"2021-07-08 21:21","market":"us","language":"en","title":"U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184325113","media":"Reuters","summary":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can u","content":"<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>7月8日（路透社）--百健公司（Biogen Inc.）表示，美国药品监管机构已经缩小了可以使用其阿尔茨海默病药物的患者群体范围，此前该机构上个月在没有证据表明该药物对阿尔茨海默病有明显益处的情况下批准了该药物，招致了尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国美国食品和药物管理局因其允许在患者中广泛使用百健公司的 Aduhelm 的决定而受到批评，尽管该公司只在淀粉样蛋白脑斑块成分检测呈阳性的早期疾病患者身上测试了这种药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但还是获得了批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>美国食品和药物管理局顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健公司表示，在 “与美国食品和药物管理局、医生和患者权益倡导者对话 ”后，它已要求更新药品标签（药品随附的书面信息）。“百健在一份声明中说：”我们的目的是帮助开处方的医生与病人互动。</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，该药物的治疗应在轻度认知障碍或轻度痴呆阶段的患者中开始。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities 分析师 Robyn Karnauskas 在一份报告中表示，新的患者群体与该药物的预期使用方式基本一致。她预计到 2031 年销售额峰值将达到约 120 亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健公司的药物受到了患者权益倡导者和一些渴望治疗这种剥夺记忆疾病的神经科医生的好评。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-07-08 21:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>7月8日（路透社）--百健公司（Biogen Inc.）表示，美国药品监管机构已经缩小了可以使用其阿尔茨海默病药物的患者群体范围，此前该机构上个月在没有证据表明该药物对阿尔茨海默病有明显益处的情况下批准了该药物，招致了尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国美国食品和药物管理局因其允许在患者中广泛使用百健公司的 Aduhelm 的决定而受到批评，尽管该公司只在淀粉样蛋白脑斑块成分检测呈阳性的早期疾病患者身上测试了这种药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但还是获得了批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>美国食品和药物管理局顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健公司表示，在 “与美国食品和药物管理局、医生和患者权益倡导者对话 ”后，它已要求更新药品标签（药品随附的书面信息）。“百健在一份声明中说：”我们的目的是帮助开处方的医生与病人互动。</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，该药物的治疗应在轻度认知障碍或轻度痴呆阶段的患者中开始。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities 分析师 Robyn Karnauskas 在一份报告中表示，新的患者群体与该药物的预期使用方式基本一致。她预计到 2031 年销售额峰值将达到约 120 亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健公司的药物受到了患者权益倡导者和一些渴望治疗这种剥夺记忆疾病的神经科医生的好评。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184325113","content_text":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.\nShares of the company fell nearly 3% before the bell on Thursday.\nThe U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.\nAduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.\nSeveral members of the FDA’s advisory panel have resigned in protest over the approval.\nBiogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.\nThe new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.\nIt also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.\nThe new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.\nBiogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157264925,"gmtCreate":1625584172867,"gmtModify":1631884986880,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/157264925","repostId":"1122401659","repostType":4,"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157262209,"gmtCreate":1625584128801,"gmtModify":1631884986890,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No.no.no","listText":"No.no.no","text":"No.no.no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/157262209","repostId":"1150315172","repostType":4,"repost":{"id":"1150315172","kind":"news","pubTimestamp":1625582925,"share":"https://www.laohunote.com/m/news/1150315172?lang=zh_CN&edition=full","pubTime":"2021-07-06 22:48","market":"us","language":"en","title":"Oil Slips as OPEC+ Uncertainty Raises Concerns of Oversupply<blockquote>欧佩克+不确定性引发供应过剩担忧，油价下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1150315172","media":"Bloomberg","summary":" -- Oil in New York edged lower amid concerns that OPEC+’s failure to ratify an agreement may lead producers to lose the discipline they have maintained against rising demand.West Texas Intermediate futures for August fell as much as 1.3% in New York. With the collapse of talks on Monday, the Organization of Petroleum Exporting Countries and its allies won’t boost output in August, unless an agreement can be salvaged. The lack of OPEC+ unity could invite new barrels to the market and spell beari","content":"<p><div> (Bloomberg) -- Oil in New York edged lower amid concerns that OPEC+’s failure to ratify an agreement may lead producers to lose the discipline they have maintained against rising demand. West Texas ...</p><p><blockquote><div>(彭博社）--纽约油价小幅下跌，原因是人们担心欧佩克+未能批准协议可能会导致生产商失去他们在应对不断增长的需求时保持的纪律。西德克萨斯……</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html\">网页连接</a></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil Slips as OPEC+ Uncertainty Raises Concerns of Oversupply<blockquote>欧佩克+不确定性引发供应过剩担忧，油价下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil Slips as OPEC+ Uncertainty Raises Concerns of Oversupply<blockquote>欧佩克+不确定性引发供应过剩担忧，油价下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-07-06 22:48</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> (Bloomberg) -- Oil in New York edged lower amid concerns that OPEC+’s failure to ratify an agreement may lead producers to lose the discipline they have maintained against rising demand. West Texas ...</p><p><blockquote><div>(彭博社）--纽约油价小幅下跌，原因是人们担心欧佩克+未能批准协议可能会导致生产商失去他们在应对不断增长的需求时保持的纪律。西德克萨斯……</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/u-oil-price-jumps-six-074615967.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150315172","content_text":"(Bloomberg) -- Oil in New York edged lower amid concerns that OPEC+’s failure to ratify an agreement may lead producers to lose the discipline they have maintained against rising demand.\nWest Texas Intermediate futures for August fell as much as 1.3% in New York. With the collapse of talks on Monday, the Organization of Petroleum Exporting Countries and its allies won’t boost output in August, unless an agreement can be salvaged. The lack of OPEC+ unity could invite new barrels to the market and spell bearish news for current prices, said Tom Finlon of Brownsville GTR LLC, a trading and logistics firm based in Houston.\n“I think if you have 23 oil-producing countries that are party to an agreement, and that agreement isn’t extended, and the price of crude is in the mid-70s, that’s an engraved invitation to overproduce,” said Finlon.\nOil prices have rallied this year, as vaccination rates and economic reopening around the world have spurred fuel consumption. The extent to which the rally continues depends largely on OPEC+ ability to reach an agreement to limit output.\nTuesday’s decline cames as most commodity and stock markets fell and the dollar edged higher.\nDiscussions among the alliance dissolved acrimoniously as the United Arab Emirates blocked a proposal led by Saudi Arabia and Russia. While the situation is fluid and negotiations could be reactivated, the breakdown has damaged the group’s image as a responsible steward of the market.\nWTI earlier hit the highest since November 2014, as the breakdown in talks left the market without the extra supplies for next month it had been counting on. Analysts from Citigroup Inc. to UBS Group AG warned that withholding extra supplies as demand recovers rapidly from the coronavirus pandemic will push prices higher.\nA repeat of last year’s destructive price war, which sent oil crashing, is also no longer a “negligible” prospect, Goldman warned.\n“If there’s any indication that the UAE folks are adding barrels, there’s a chance, probably a good chance that others within the producer group will try and beat them to the punch,” said Bob Yawger, head of the futures division at Mizuho Securities.\nOil and Dollars: Why the UAE Is Risking a Falling-Out With OPEC+\nOil’s rally has been accompanied by sharp moves in price spreads between monthly contracts, an indication that traders see supply conditions growing tighter. The premium of Brent’s November contract over December jumped to 81 cents a barrel from 73 cents on Friday.\nThe 23-nation OPEC+ coalition had been on the brink of an agreement to restore production halted during the pandemic, in monthly increments of 400,000 barrels a day. That plan could still be ratified, or members may choose to informally leak barrels to eager consumers.\n“A compromise will be reached which should allow additional barrels into the market from August,” said Ole Hansen, head of commodities research at Saxo Bank A/S. “The political pressure from large consumers such as India and China will grow, with Washington probably also adding some pressure.”\nTraders will also look to crude and gasoline inventories in the U.S. last week for signals about demand in the world’s biggest oil-consuming country, in the industry-funded American Petroleum Institute report released later Tuesday.","news_type":1,"symbols_score_info":{"CLmain":0.9}},"isVote":1,"tweetType":1,"viewCount":3046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152614613,"gmtCreate":1625287271232,"gmtModify":1631884986900,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/152614613","repostId":"1140994998","repostType":4,"isVote":1,"tweetType":1,"viewCount":2665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124008630,"gmtCreate":1624702194220,"gmtModify":1631884986913,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/124008630","repostId":"2146008543","repostType":4,"isVote":1,"tweetType":1,"viewCount":2887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184553760,"gmtCreate":1623719573950,"gmtModify":1631884986924,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Agreed 👍","listText":"Agreed 👍","text":"Agreed 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/184553760","repostId":"2143178756","repostType":4,"isVote":1,"tweetType":1,"viewCount":2854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182881408,"gmtCreate":1623562731504,"gmtModify":1634031633499,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>: 這篇文章不錯，轉發給大家看看","listText":"Good//<a href=\"https://laohu8.com/U/3570755698252810\">@螞蟻東尼</a>: 這篇文章不錯，轉發給大家看看","text":"Good//@螞蟻東尼: 這篇文章不錯，轉發給大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/182881408","repostId":"181297335","repostType":1,"repost":{"id":181297335,"gmtCreate":1623395075523,"gmtModify":1623434242396,"author":{"id":"3468322318173915","authorId":"3468322318173915","name":"阳光财经","avatar":"https://static.tigerbbs.com/ae4ab676f150a8d357cb5f3e4956d1a0","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3468322318173915","idStr":"3468322318173915"},"themes":[],"title":"","htmlText":"\n \n \n  美股分析：这么一大利空，标普创新高无果。\n \n","listText":"美股分析：这么一大利空，标普创新高无果。","text":"美股分析：这么一大利空，标普创新高无果。","images":[],"top":1,"highlighted":2,"essential":2,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181297335","isVote":1,"tweetType":2,"object":{"id":"4174a0e07fd04f3098232a70d1dd45ea","tweetId":"181297335","title":"美股分析：这么一大利空，标普创新高无果。","videoUrl":"http://v.tigerbbs.com/1623395070474792f422fd34b3bb27bec3468d08fc440.mp4","poster":"https://static.tigerbbs.com/1ee8b26d625d5af0cd80aa1c4bebbec2","shareLink":"http://v.tigerbbs.com/1623395070474792f422fd34b3bb27bec3468d08fc440.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":182881100,"gmtCreate":1623562698800,"gmtModify":1634031633968,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/182881100","repostId":"2143788707","repostType":4,"isVote":1,"tweetType":1,"viewCount":1069,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188444184,"gmtCreate":1623460391448,"gmtModify":1634032942475,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/188444184","repostId":"2142025622","repostType":4,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189475315,"gmtCreate":1623287205237,"gmtModify":1634034970994,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Haiz&nbsp;","listText":"Haiz&nbsp;","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189475315","repostId":"1114317619","repostType":4,"isVote":1,"tweetType":1,"viewCount":1054,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180448661,"gmtCreate":1623223279953,"gmtModify":1634035636941,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"It Is game over","listText":"It Is game over","text":"It Is game over","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/180448661","repostId":"1158084619","repostType":4,"isVote":1,"tweetType":1,"viewCount":1023,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116022736,"gmtCreate":1622766990325,"gmtModify":1634098269303,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Unbelievable&nbsp;","listText":"Unbelievable&nbsp;","text":"Unbelievable","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/116022736","repostId":"1182776229","repostType":4,"isVote":1,"tweetType":1,"viewCount":1001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118027850,"gmtCreate":1622709065270,"gmtModify":1634098921739,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/118027850","repostId":"2140705444","repostType":4,"isVote":1,"tweetType":1,"viewCount":965,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":118025774,"gmtCreate":1622709012898,"gmtModify":1634098922670,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/118025774","repostId":"1177656700","repostType":4,"isVote":1,"tweetType":1,"viewCount":934,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111051293,"gmtCreate":1622645660512,"gmtModify":1634099605722,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;&nbsp;","listText":"Good&nbsp;&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/111051293","repostId":"1169651707","repostType":4,"isVote":1,"tweetType":1,"viewCount":1027,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119980435,"gmtCreate":1622513195027,"gmtModify":1634100937262,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good move","listText":"Good move","text":"Good move","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119980435","repostId":"1198461252","repostType":2,"isVote":1,"tweetType":1,"viewCount":921,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":110338041,"gmtCreate":1622424890383,"gmtModify":1634101621537,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/110338041","repostId":"2139487366","repostType":2,"repost":{"id":"2139487366","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622359710,"share":"https://www.laohunote.com/m/news/2139487366?lang=zh_CN&edition=full","pubTime":"2021-05-30 15:28","language":"en","title":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克贸易暂停继续 凌晨 03:28 不可用原因</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2139487366","media":"Reuters","summary":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM","content":"<p><html><body>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM</p><p><blockquote><html><body>纳斯达克贸易暂停继续 凌晨 03:28 不可用原因</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克贸易暂停继续 凌晨 03:28 不可用原因</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM<blockquote>纳斯达克贸易暂停继续 凌晨 03:28 不可用原因</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-05-30 15:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM</p><p><blockquote><html><body>纳斯达克贸易暂停继续 凌晨 03:28 不可用原因</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QLD":"2倍做多纳斯达克100指数ETF-ProShares",".IXIC":"NASDAQ Composite","IMC.AU":"IMMURON LTD","QQQ":"纳指100ETF","NDAQ":"纳斯达克OMX交易所","QID":"两倍做空纳斯达克指数ETF-ProShares","PSQ":"做空纳斯达克100指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","SQQQ":"纳指三倍做空ETF"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2139487366","content_text":"NASDAQ TRADE HALT CONTINUES    REASON NOT AVAILABLE AT 03:28 AM","news_type":1,"symbols_score_info":{"MNQmain":0.6,"NDAQ":1,"IMC.AU":0.9,"QQQ":0.6,"SQQQ":0.6,"QID":0.6,"PSQ":0.6,"QLD":0.6,"NQmain":0.6,"TQQQ":0.6,".IXIC":1}},"isVote":1,"tweetType":1,"viewCount":944,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138421328,"gmtCreate":1621955130864,"gmtModify":1634185157902,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Yes&nbsp;","listText":"Yes&nbsp;","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/138421328","repostId":"2138193568","repostType":2,"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184553760,"gmtCreate":1623719573950,"gmtModify":1631884986924,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Agreed 👍","listText":"Agreed 👍","text":"Agreed 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/184553760","repostId":"2143178756","repostType":4,"isVote":1,"tweetType":1,"viewCount":2854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189475315,"gmtCreate":1623287205237,"gmtModify":1634034970994,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Haiz&nbsp;","listText":"Haiz&nbsp;","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189475315","repostId":"1114317619","repostType":4,"isVote":1,"tweetType":1,"viewCount":1054,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":194661884,"gmtCreate":1621378393248,"gmtModify":1634192110798,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Wow&nbsp;","listText":"Wow&nbsp;","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/194661884","repostId":"2135161248","repostType":4,"repost":{"id":"2135161248","kind":"news","pubTimestamp":1621343169,"share":"https://www.laohunote.com/m/news/2135161248?lang=zh_CN&edition=full","pubTime":"2021-05-18 21:06","market":"us","language":"en","title":"JD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将公布第一季度收益：前景如何？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2135161248","media":"Zacks","summary":"JD.com, Inc. is scheduled to report first-quarter 2021 results on May 19.\nFor the first quarter, the","content":"<p><b>JD.com, Inc.</b>&nbsp;is scheduled to report first-quarter 2021 results on May 19.</p><p><blockquote><b>京东公司。</b>定于 5 月 19 日公布 2021 年第一季度业绩。</blockquote></p><p> For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.</p><p><blockquote>Zacks 对第一季度收入的一致预期为 299 亿美元，比去年同期报告的数字增长了 44.9%。</blockquote></p><p> Further, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.</p><p><blockquote>此外，每股收益的共识为 39 美分，比上一年报告的数字增长了 39.3%。</blockquote></p><p> Notably, the company delivered an earnings surprise of 4.6% in the last reported quarter.</p><p><blockquote>值得注意的是，该公司在上一季度的盈利意外增长了 4.6%。</blockquote></p><p> <b>JD.com, Inc. Price and EPS Surprise</b></p><p><blockquote><b>京东公司。价格和每股收益惊喜</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c1fed1c36f6a8ce20878c0d2e594f77c\" tg-width=\"534\" tg-height=\"262\"><span>JD.com, Inc. price-eps-surprise | JD.com, Inc. Quote</span></p><p><blockquote><p class=\"t-img-caption\"><span>京东公司价格-每股收益-惊喜 |京东公司报价</span></p></blockquote></p><p> <b>Key Factors to Note</b></p><p><blockquote><b>需要注意的关键因素</b></blockquote></p><p> The company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.</p><p><blockquote>该公司的京东零售部门（包括电子商务业务）预计将成为第一季度的主要催化剂。</blockquote></p><p> The launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.</p><p><blockquote>John Lobb、Stefano Ricci、Vivienne Westwoodon 和 Anya Hindmarch 等热门时尚和奢侈品牌在京东开设旗舰店可能会推动顾客增长，进而有望帮助京东零售在报告季度的表现。</blockquote></p><p> JD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.</p><p><blockquote>京东零售的全渠道计划预计将极大地促进该部门第一季度的营收增长。</blockquote></p><p> Moreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.</p><p><blockquote>此外，该公司与意大利奢侈品牌 Prada 和 MiuMiu 的合作，加强了其全渠道业务，这可能是一个积极因素。</blockquote></p><p> Furthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.</p><p><blockquote>此外，京东健康提供免费在线医疗咨询和在线药房零售服务，其发展势头可能会反映在该公司即将公布的季度业绩中。</blockquote></p><p> Growing investments in research and development are also likely to have been encouraging for the company in the quarter under review.</p><p><blockquote>在本季度，不断增长的研发投资也可能对该公司来说是令人鼓舞的。</blockquote></p><p> Additionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.</p><p><blockquote>此外，包括技术、供应链和物流服务在内的新业务部门预计将帮助其在第一季度在低线城市获得牵引力。</blockquote></p><p> Moreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.</p><p><blockquote>此外，表现良好的京西商业集团有望帮助京东在低线城市的表现。</blockquote></p><p> However, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.</p><p><blockquote>然而，履行、营销和研发费用的增加很可能是公司本季度盈利能力的主要风险。</blockquote></p><p> Moreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.</p><p><blockquote>此外，阿里巴巴-SW在电子商务市场上日益增加的竞争压力可能会反映在第一季度的业绩中。</blockquote></p><p> <b>What Our Model Says</b></p><p><blockquote><b>我们的模型说什么</b></blockquote></p><p> Our proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.</p><p><blockquote>我们经过验证的模型并不能最终预测京东这次的盈利会超出预期。正收益扩展 Zacks 排名 #1（强力买入）、2（买入）或 3（持有）的组合会增加收益超出预期的几率。但这里并非如此。使用 ourEarnings ESP 过滤器，您可以在股票被报道之前发现最值得买卖的股票。</blockquote></p><p> JD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.</p><p><blockquote>京东目前的盈利 ESP 为 -14.83%，Zacks 排名第 5（强力抛售）。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将公布第一季度收益：前景如何？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD.com to Report Q1 Earnings: What's in the Cards?<blockquote>京东将公布第一季度收益：前景如何？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2021-05-18 21:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>JD.com, Inc.</b>&nbsp;is scheduled to report first-quarter 2021 results on May 19.</p><p><blockquote><b>京东公司。</b>定于 5 月 19 日公布 2021 年第一季度业绩。</blockquote></p><p> For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.</p><p><blockquote>Zacks 对第一季度收入的一致预期为 299 亿美元，比去年同期报告的数字增长了 44.9%。</blockquote></p><p> Further, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.</p><p><blockquote>此外，每股收益的共识为 39 美分，比上一年报告的数字增长了 39.3%。</blockquote></p><p> Notably, the company delivered an earnings surprise of 4.6% in the last reported quarter.</p><p><blockquote>值得注意的是，该公司在上一季度的盈利意外增长了 4.6%。</blockquote></p><p> <b>JD.com, Inc. Price and EPS Surprise</b></p><p><blockquote><b>京东公司。价格和每股收益惊喜</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c1fed1c36f6a8ce20878c0d2e594f77c\" tg-width=\"534\" tg-height=\"262\"><span>JD.com, Inc. price-eps-surprise | JD.com, Inc. Quote</span></p><p><blockquote><p class=\"t-img-caption\"><span>京东公司价格-每股收益-惊喜 |京东公司报价</span></p></blockquote></p><p> <b>Key Factors to Note</b></p><p><blockquote><b>需要注意的关键因素</b></blockquote></p><p> The company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.</p><p><blockquote>该公司的京东零售部门（包括电子商务业务）预计将成为第一季度的主要催化剂。</blockquote></p><p> The launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.</p><p><blockquote>John Lobb、Stefano Ricci、Vivienne Westwoodon 和 Anya Hindmarch 等热门时尚和奢侈品牌在京东开设旗舰店可能会推动顾客增长，进而有望帮助京东零售在报告季度的表现。</blockquote></p><p> JD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.</p><p><blockquote>京东零售的全渠道计划预计将极大地促进该部门第一季度的营收增长。</blockquote></p><p> Moreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.</p><p><blockquote>此外，该公司与意大利奢侈品牌 Prada 和 MiuMiu 的合作，加强了其全渠道业务，这可能是一个积极因素。</blockquote></p><p> Furthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.</p><p><blockquote>此外，京东健康提供免费在线医疗咨询和在线药房零售服务，其发展势头可能会反映在该公司即将公布的季度业绩中。</blockquote></p><p> Growing investments in research and development are also likely to have been encouraging for the company in the quarter under review.</p><p><blockquote>在本季度，不断增长的研发投资也可能对该公司来说是令人鼓舞的。</blockquote></p><p> Additionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.</p><p><blockquote>此外，包括技术、供应链和物流服务在内的新业务部门预计将帮助其在第一季度在低线城市获得牵引力。</blockquote></p><p> Moreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.</p><p><blockquote>此外，表现良好的京西商业集团有望帮助京东在低线城市的表现。</blockquote></p><p> However, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.</p><p><blockquote>然而，履行、营销和研发费用的增加很可能是公司本季度盈利能力的主要风险。</blockquote></p><p> Moreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.</p><p><blockquote>此外，阿里巴巴-SW在电子商务市场上日益增加的竞争压力可能会反映在第一季度的业绩中。</blockquote></p><p> <b>What Our Model Says</b></p><p><blockquote><b>我们的模型说什么</b></blockquote></p><p> Our proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.</p><p><blockquote>我们经过验证的模型并不能最终预测京东这次的盈利会超出预期。正收益扩展 Zacks 排名 #1（强力买入）、2（买入）或 3（持有）的组合会增加收益超出预期的几率。但这里并非如此。使用 ourEarnings ESP 过滤器，您可以在股票被报道之前发现最值得买卖的股票。</blockquote></p><p> JD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.</p><p><blockquote>京东目前的盈利 ESP 为 -14.83%，Zacks 排名第 5（强力抛售）。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zacks.com/stock/news/1541348/jdcom-jd-to-report-q1-earnings-whats-in-the-cards?art_rec=quote-stock_overview-zacks_news-ID02-txt-1541348\">Zacks</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09618":"京东集团-SW","JD":"京东"},"source_url":"https://www.zacks.com/stock/news/1541348/jdcom-jd-to-report-q1-earnings-whats-in-the-cards?art_rec=quote-stock_overview-zacks_news-ID02-txt-1541348","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2135161248","content_text":"JD.com, Inc. is scheduled to report first-quarter 2021 results on May 19.\nFor the first quarter, the Zacks Consensus Estimate for revenues is pegged at $29.9 billion, indicating an improvement of 44.9% from the year-ago reported figure.\nFurther, the consensus mark for earnings is pegged at 39 cents per share, indicating a 39.3% rise from the previous-year reported figure.\nNotably, the company delivered an earnings surprise of 4.6% in the last reported quarter.\nJD.com, Inc. Price and EPS Surprise\nJD.com, Inc. price-eps-surprise | JD.com, Inc. Quote\nKey Factors to Note\nThe company’s JD Retail segment, comprising the e-commerce business, is expected to have been the key catalyst in the first quarter.\nThe launch of flagship stores of popular fashion and luxury brands like John Lobb, Stefano Ricci, Vivienne Westwoodon and Anya Hindmarch, among others, on JD.com is likely to have driven customer momentum, which in turn is expected to have aided the performance of JD Retail during the quarter-to-be-reported.\nJD retail’s omni-channel initiatives are anticipated to have contributed well to top-line growth of the segment in the first quarter.\nMoreover, the company’s collaboration with Italian luxury brands Prada and MiuMiu, which bolstered its omni-channel efforts, might have been a positive.\nFurthermore, growing momentum of JD health that offers free online medical consultation and online pharmacy retail services is likely to get reflected in the company’s to-be-reported quarter’s results.\nGrowing investments in research and development are also likely to have been encouraging for the company in the quarter under review.\nAdditionally, the new businesses segment comprising technology, supply chain and logistics services is expected to have helped it in gaining traction across lower-tier cities in the first quarter.\nMoreover, the well-performing Jingxi Business Group is expected to have aided JD.com’s performance in the lower-tier cities.\nHowever, increasing fulfilment, marketing, and research and development expenses are likely to have been major risks to the company’s profitability in the quarter under review.\nMoreover, increasing competitive pressure from Alibaba in the e-commerce market might be reflected in first-quarter results.\nWhat Our Model Says\nOur proven model does not conclusively predict an earnings beat for JD.com this time around. The combination of a positiveEarnings ESPand a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with ourEarnings ESP Filter.\nJD.com has an Earnings ESP of -14.83% and a Zacks Rank #5 (Strong Sell), at present.","news_type":1,"symbols_score_info":{"09618":0.9,"JD":0.9}},"isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157264925,"gmtCreate":1625584172867,"gmtModify":1631884986880,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/157264925","repostId":"1122401659","repostType":4,"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182881100,"gmtCreate":1623562698800,"gmtModify":1634031633968,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/182881100","repostId":"2143788707","repostType":4,"isVote":1,"tweetType":1,"viewCount":1069,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111051293,"gmtCreate":1622645660512,"gmtModify":1634099605722,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good&nbsp;&nbsp;","listText":"Good&nbsp;&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/111051293","repostId":"1169651707","repostType":4,"isVote":1,"tweetType":1,"viewCount":1027,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170737981,"gmtCreate":1626450507243,"gmtModify":1631884986830,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170737981","repostId":"1179740731","repostType":4,"isVote":1,"tweetType":1,"viewCount":2740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143092981,"gmtCreate":1625751825943,"gmtModify":1631884986868,"author":{"id":"3577341055310022","authorId":"3577341055310022","name":"Pink004","avatar":"https://static.tigerbbs.com/c590727a3303e194d648430bed8b44a1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577341055310022","idStr":"3577341055310022"},"themes":[],"title":"","htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/143092981","repostId":"1184325113","repostType":4,"repost":{"id":"1184325113","kind":"news","pubTimestamp":1625750497,"share":"https://www.laohunote.com/m/news/1184325113?lang=zh_CN&edition=full","pubTime":"2021-07-08 21:21","market":"us","language":"en","title":"U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1184325113","media":"Reuters","summary":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can u","content":"<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>7月8日（路透社）--百健公司（Biogen Inc.）表示，美国药品监管机构已经缩小了可以使用其阿尔茨海默病药物的患者群体范围，此前该机构上个月在没有证据表明该药物对阿尔茨海默病有明显益处的情况下批准了该药物，招致了尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国美国食品和药物管理局因其允许在患者中广泛使用百健公司的 Aduhelm 的决定而受到批评，尽管该公司只在淀粉样蛋白脑斑块成分检测呈阳性的早期疾病患者身上测试了这种药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但还是获得了批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>美国食品和药物管理局顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健公司表示，在 “与美国食品和药物管理局、医生和患者权益倡导者对话 ”后，它已要求更新药品标签（药品随附的书面信息）。“百健在一份声明中说：”我们的目的是帮助开处方的医生与病人互动。</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，该药物的治疗应在轻度认知障碍或轻度痴呆阶段的患者中开始。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities 分析师 Robyn Karnauskas 在一份报告中表示，新的患者群体与该药物的预期使用方式基本一致。她预计到 2031 年销售额峰值将达到约 120 亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健公司的药物受到了患者权益倡导者和一些渴望治疗这种剥夺记忆疾病的神经科医生的好评。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA narrows patient group for Biogen's Alzheimer's drug<blockquote>美国 FDA 缩小百健阿尔茨海默病药物的患者范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-07-08 21:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.</p><p><blockquote>7月8日（路透社）--百健公司（Biogen Inc.）表示，美国药品监管机构已经缩小了可以使用其阿尔茨海默病药物的患者群体范围，此前该机构上个月在没有证据表明该药物对阿尔茨海默病有明显益处的情况下批准了该药物，招致了尖锐批评。</blockquote></p><p> Shares of the company fell nearly 3% before the bell on Thursday.</p><p><blockquote>该公司股价周四盘前下跌近3%。</blockquote></p><p> The U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.</p><p><blockquote>美国美国食品和药物管理局因其允许在患者中广泛使用百健公司的 Aduhelm 的决定而受到批评，尽管该公司只在淀粉样蛋白脑斑块成分检测呈阳性的早期疾病患者身上测试了这种药物。</blockquote></p><p> Aduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.</p><p><blockquote>Aduhelm，也称为aducanumab，尽管缺乏明确的证据表明该药物有效，并且违背了外部顾问小组的建议，但还是获得了批准。</blockquote></p><p> Several members of the FDA’s advisory panel have resigned in protest over the approval.</p><p><blockquote>美国食品和药物管理局顾问小组的几名成员已经辞职，以抗议批准。</blockquote></p><p> Biogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.</p><p><blockquote>百健公司表示，在 “与美国食品和药物管理局、医生和患者权益倡导者对话 ”后，它已要求更新药品标签（药品随附的书面信息）。“百健在一份声明中说：”我们的目的是帮助开处方的医生与病人互动。</blockquote></p><p> The new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.</p><p><blockquote>新标签称，该药物的治疗应在轻度认知障碍或轻度痴呆阶段的患者中开始。</blockquote></p><p> It also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.</p><p><blockquote>它还表示，没有关于在疾病早期或晚期开始治疗的安全性或有效性数据。</blockquote></p><p> The new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.</p><p><blockquote>Truist Securities 分析师 Robyn Karnauskas 在一份报告中表示，新的患者群体与该药物的预期使用方式基本一致。她预计到 2031 年销售额峰值将达到约 120 亿美元。</blockquote></p><p> Biogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.</p><p><blockquote>百健公司的药物受到了患者权益倡导者和一些渴望治疗这种剥夺记忆疾病的神经科医生的好评。其他医生表示，临床试验结果不一致，需要更多证据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.reuters.com/article/biogen-alzheimers-fda/update-2-u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug-idUSL3N2OK2XT","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184325113","content_text":"July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer’s disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.\nShares of the company fell nearly 3% before the bell on Thursday.\nThe U.S. Food and Drug Administration has been criticized for its decision to allow wide use of Biogen’s Aduhelm among patients even though the company had tested the drug only in patients with early disease who tested positive for a component of amyloid brain plaques.\nAduhelm, also known as aducanumab, was approved despite a lack of clear evidence showing the drug worked and against the advice of an outside group of advisers.\nSeveral members of the FDA’s advisory panel have resigned in protest over the approval.\nBiogen said it had asked for an update to the label, a written information that accompanies a drug, after “dialogue with FDA, physicians and patient advocates.” “The intent is to help prescribing physicians to engage with patients,” Biogen said in a statement.\nThe new label says that treatment with the drug should be initiated in patients with mild cognitive impairment or mild dementia stage of the disease.\nIt also says there is no safety or effectiveness data on initiating treatment at earlier or later stages of the disease.\nThe new patient population is largely in-line with how the drug was expected to be used, Truist Securities analyst Robyn Karnauskas said in a note. She expects roughly $12 billion in peak sales by 2031.\nBiogen’s drug has been hailed by patient advocates and some neurologists eager for a treatment for the memory-robbing disease. Other doctors said clinical trial results were inconsistent and more proof was needed.","news_type":1,"symbols_score_info":{"BIIB":0.9}},"isVote":1,"tweetType":1,"viewCount":2243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}